Effects of autoimmune disorders on daily lifestyle
DOI:
https://doi.org/10.12775/JEHS.2022.12.12.038Keywords
autoimmune disease, lupus erythematosus, connective tissue, neuropsychiatryAbstract
Systemic diseases of connective tissue are a group of diseases of unspecified aetiology and pathogenesis. They are based on the autoimmune process. It can involve single organs as well as whole systems. Neuropsychiatric complications in systemic connective tissue diseases are of interest to both neurologists and rheumatologists and specialists in other fields. These complications may occur with different frequency – from 30-80% and result from the involvement of individual structures of the central and peripheral nervous system. They can be divided into primary, i.e. resulting from the underlying disease, and secondary, which are most often the result of the applied treatment.
The most common psychopathological symptoms include: progressive cognitive disorders, emotional lability, mood and sleep disorders, as well as memory disorders, psychosensory disorders, depersonalisation, derealisation, depressed mood, anxiety states, hallucinations, persecutory delusions. Diagnosing the cause of psychiatric disorders is the basis for introducing appropriate causal treatment, which should be supplemented by symptomatic psychiatric therapy.
References
Dantzer R, Kelly KW. Twenty years of research on cytokine – induced sickness behavior. Brain Behav Immun 2007;21: 441-460
A. Daca, E. Bryl, Toczeń rumieniowaty układowy – kryteria diagnostyczne i kliniczne skale oceny aktywności choroby – rys historyczny, „Forum Medycyny Rodzinnej” 2013, t. 7, nr 5, s. 225-243
Bogaczewicz A., Sobów T., Bogaczewicz J., Ząbek J., Bieńkowski P., Kowalski J., Robak E., Sysa-Jędrzejowska A., Woźniacka A. Zaburzenia psychiczne w toczniu rumieniowatym układowym, Aktualn. Neurol 2013, 13 (3), p. 168–178
Bertsias G.K., Ioannidis J.P., Boletis J. i wsp.: EULAR points to consider for conducting clinical trials in systemie lupus erythematosus: literature based evidence for the selection of endpoints. Ann. Rheum. Dis. 2009; 68: 477–483
Celińska-Löwenhoff M., Musiał J., Zaburzenia psychiczne w chorobach autoimmunologicznych- problemy diagnostyczno-terapeutyczne, Psychiatria Polska 2012, tom XLVI, numer 6, 1029–1042
Meszaros ZS, Perl A, Faraone SV. Psychiatric Symptoms In Systemic Lupus Erythematosus: A Systematic Review. Clin. Psychiatry 2012; 73(7): 993–1001
Hughes GRV. Antiphospholipid syndrome (Hughes syndrome): ten clinical topics. Lupus 2010;19:343-6
Ostanek L. Antiphospholipid syndrome Reumatologia 2016; supl. 1: 36–44
Fabrycy-Fiedorowicz I. Brzosko M. Objawy ze strony układu nerwowego w przebiegu chorób reumatycznych. W: Zimmermann-Górska I. red. Reumatologia kliniczna, wyd. 1. Warszawa, Wydawnictwo Lekarskie PZWL; 2008. s. 1103–1113
Furmańczyk A, Komuda-Leszek E, Gadomska W, Windyga J, Durlik M. Catastrophic antiphospholipid syndrome. Pol. Arch. Med. Wewn. 2009; 119: 427–430
Tomietto P, Annese V, D’agostini S i wsp. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007;57:1461-1472
Firestein GS, Budd RC,Harris ED Jr, McInnes IB, Ruddy S, Sergent JS. Ethiology and pathogenesis of rheumatoidarthritis. red. Kelly’stextbook of rheumatology, volume II. Philadelphia: Saunders Elsevier; 2009. s. 1035–1086
Targońska-Stępniak B, Majdan M. Associations between parameters of nutritional status and disease activity in patients with rheumatoid arthritis. Pol. Arch. Med. Wewn. 2011; 121: 122–128
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389
Matcham F, Rayner L, Steer S i wsp. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 2013;52:2136-2148
Puszczewicz M. Sjögren’s syndrome, Reumatologia 2016; supl. 1: 72–73
Kruk K., Rzepakowska A., Osuch-Wójcikiewicz E., Niemczyk K. Sjögren’s syndrom – the review of the latest diagnostic guidelines essential for otolaryngologists, Sjögren’s syndrom – the review of the latest diagnostic guidelines essential for otolaryngologists 2020
Fabrycy-Fiedorowicz I. Brzosko M. Objawy ze strony układu nerwowego w przebiegu chorób reumatycznych. W: Zimmermann-Górska I. red. Reumatologia kliniczna, wyd. 1. Warszawa, Wydawnictwo Lekarskie PZWL; 2008. s. 1103–1113
Sulik A., Lewszuk A., Kochanowicz J., Domysławska I., Gińdzieńska-Sieśkiewicz E., Łebkowska U., Walecki J., Mariak Z., Sierakowski S. Systemic sclerosis with central nervous system involvement: brain abnormalities revealed by magnetic resonance imaging Reumatologia 2010; 48, 6: 410–415
Angelopoulos NV, Drosos AA, Moutsopoulos HM. Psychiatric symptoms associated with scleroderma. Psychother Psychosom 2001; 70: 145-150
Tezuka T, Azuma M, Goto H i wsp. Psychiatric symptoms in a patient with Churg-Strauss syndrome. Intern Med 2012;51:301-303
Basu N, Mc Clean A, Harper L i wsp. Explaining fatigue in ANCA-associated vasculitis. Rheumatol 2013;52:1680-1685
Wolkowitz OM, Burke H, Epel ES, Reus VI. Glucocorticoids. Mood, memory, and mechanisms. Ann. N. Y. Acad. Sci. 2009; 1179: 19–40
Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann. Allergy Asthma Immunol. 2004; 92: 500–505
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Kinga Kawałko, Grzegorz Rynio, Kamil Pondel, Anna Karaś, Krzysztof Bielewicz, Patrycja Sufin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 267
Number of citations: 0